Inicio>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Finafloxacin

Finafloxacin

Catalog No.GC33917

Finafloxacino es un agente antimicrobiano de fluoroquinolona que muestra una eficacia Óptima en ambientes ligeramente Ácidos.

Products are for research use only. Not for human use. We do not sell to patients.

Finafloxacin Chemical Structure

Cas No.: 209342-40-5

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
282,00 $
Disponible
1mg
138,00 $
Disponible
5mg
321,00 $
Disponible
10mg
459,00 $
Disponible
50mg
1.379,00 $
Disponible
100mg
1.930,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Finafloxacin is a fluoroquinolone antimicrobial agent that exhibits optimum efficacy in slightly acidic environments. Target: AntibacterialFinafloxacin is a pH-activated fluoroquinolone (belonging to a new 8-cyano subclass) to treat serious bacterial infections associated with an acidic environment, including urinary tract infections (UTIs) and Helicobacter pylori infections. Finafloxacin exhibits optimal efficacy in slightly acidic environments (pH 5.0-6.0), under which other fluoroquinolones lose activity. Finafloxacin is highly selective for bacterial type II topoisomerases, including DNA gyrase and DNA topoisomerase IV. [1]

[1]. McKeage K. Finafloxacin: first global approval. Drugs. 2015 Apr;75(6):687-93.

Reseñas

Review for Finafloxacin

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Finafloxacin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.